Farxiga can cost between $400 and $600 without insurance, depending on the pharmacy and whether a person buys the brand drug or the generic. Whether Medicare can pay a share of this cost depends on ...

AstraZeneca is on its way to scoring a key new nod for SGLT2 diabetes drug Farxiga, and the FDA just sped things up. The agency doled out its fast track designation to Farxiga in chronic kidney ...

Negotiated lower Medicare costs for 10 popular prescription drugs went into effect Thursday. How much those savings will be ...

Full results from the cardiovascular outcomes trial for dapagliflozin (Farxiga) will be presented at the American Heart Association annual meeting in November. The diabetes drug dapagliflozin (Farxiga ...

Discovery may pave the way for a new class of medication. AstraZeneca's diabetes drug, Farxiga, has become the first in its class to receive FDA approval as a treatment for heart failure. "It's great ...

In the rush for differentiation in an increasingly competitive heart failure (HF) field, AstraZeneca can now make a singular claim. Its SGLT2 inhibitor Farxiga is the first HF drug to demonstrate that ...

PITTSBURGH — We could find out very soon if a drug used to treat diabetes will have another approved use. Right now, the FDA is deciding whether it can be used to help patients with heart failure. Dr.

Drug tested in 1,250 high-risk patients over 30 days Did not meet goal of cutting risk of disease worsening, death April 12 (Reuters) - Data from a late-stage study to test if AstraZeneca's (AZN.L), ...

LONDON, Aug 27 (Reuters) - AstraZeneca's (AZN.L), opens new tab blockbuster diabetes drug Farxiga led to significant reductions in the risk of hospitalisation and death in people with all types of ...

The U.S. Food and Drug Administration today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Type 2 diabetes affects ...